Global Biologics and Biosimilars Market Research Report 2018

Published Date : 2018-02-15

Published By : QY Research Reports

Category : Pharma & Healthcare

No. of Pages : 119

In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biologics and Biosimilars in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Biologics and Biosimilars market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Biologics and Biosimilars Market Research Report 2018
1 Biologics and Biosimilars Market Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Type (Product Category)
1.2.1 Global Biologics and Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Biologics and Biosimilars Production Market Share by Type (Product Category) in 2017
1.2.3 Antibiotic
1.2.4 Enzyme
1.2.5 Hormone
1.2.6 Non-Patented Biological Reagents
1.2.7 Other
1.3 Global Biologics and Biosimilars Segment by Application
1.3.1 Biologics and Biosimilars Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Biologics and Biosimilars Market by Region (2013-2025)
1.4.1 Global Biologics and Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Biologics and Biosimilars (2013-2025)
1.5.1 Global Biologics and Biosimilars Revenue Status and Outlook (2013-2025)
1.5.2 Global Biologics and Biosimilars Capacity, Production Status and Outlook (2013-2025)

2 Global Biologics and Biosimilars Market Competition by Manufacturers
2.1 Global Biologics and Biosimilars Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Biologics and Biosimilars Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Biologics and Biosimilars Production and Share by Manufacturers (2013-2018)
2.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2013-2018)
2.3 Global Biologics and Biosimilars Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biologics and Biosimilars Market Competitive Situation and Trends
2.5.1 Biologics and Biosimilars Market Concentration Rate
2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Biologics and Biosimilars Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Biologics and Biosimilars Capacity and Market Share by Region (2013-2018)
3.2 Global Biologics and Biosimilars Production and Market Share by Region (2013-2018)
3.3 Global Biologics and Biosimilars Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Biologics and Biosimilars Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Biologics and Biosimilars Consumption by Region (2013-2018)
4.2 North America Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
4.3 Europe Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
4.4 China Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
4.5 Japan Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
4.7 India Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

5 Global Biologics and Biosimilars Production, Revenue (Value), Price Trend by Type
5.1 Global Biologics and Biosimilars Production and Market Share by Type (2013-2018)
5.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
5.3 Global Biologics and Biosimilars Price by Type (2013-2018)
5.4 Global Biologics and Biosimilars Production Growth by Type (2013-2018)

6 Global Biologics and Biosimilars Market Analysis by Application
6.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2013-2018)
6.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Biologics and Biosimilars Manufacturers Profiles/Analysis
7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Biologics and Biosimilars Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Roche
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Biologics and Biosimilars Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Roche Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Amgen
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Biologics and Biosimilars Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 AbbVie
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Biologics and Biosimilars Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 AbbVie Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Sanofi
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Biologics and Biosimilars Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Sanofi Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Biologics and Biosimilars Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Biologics and Biosimilars Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Novartis
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Biologics and Biosimilars Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Merck
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Biologics and Biosimilars Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Merck Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Lilly
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Biologics and Biosimilars Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Lilly Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian Pharmacy
7.14 Biotech Pharma
7.15 Gelgen Biopharma
7.16 Sandoz
7.17 Teva
7.18 Hospira
7.19 Mylan

8 Biologics and Biosimilars Manufacturing Cost Analysis
8.1 Biologics and Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biologics and Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Biologics and Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Biologics and Biosimilars Market Forecast (2018-2025)
12.1 Global Biologics and Biosimilars Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Biologics and Biosimilars Price and Trend Forecast (2018-2025)
12.2 Global Biologics and Biosimilars Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Biologics and Biosimilars Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Biologics and Biosimilars Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


List of Tables and Figures

Figure Picture of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biologics and Biosimilars Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Antibiotic
Table Major Manufacturers of Antibiotic
Figure Product Picture of Enzyme
Table Major Manufacturers of Enzyme
Figure Product Picture of Hormone
Table Major Manufacturers of Hormone
Figure Product Picture of Non-Patented Biological Reagents
Table Major Manufacturers of Non-Patented Biological Reagents
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Biologics and Biosimilars Consumption (K Units) by Applications (2013-2025)
Figure Global Biologics and Biosimilars Consumption Market Share by Applications in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Biologics and Biosimilars Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biologics and Biosimilars Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Biologics and Biosimilars Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Biologics and Biosimilars Major Players Product Capacity (K Units) (2013-2018)
Table Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers in 2017
Figure Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers in 2018
Figure Global Biologics and Biosimilars Major Players Product Production (K Units) (2013-2018)
Table Global Biologics and Biosimilars Production (K Units) of Key Manufacturers (2013-2018)
Table Global Biologics and Biosimilars Production Share by Manufacturers (2013-2018)
Figure 2017 Biologics and Biosimilars Production Share by Manufacturers
Figure 2017 Biologics and Biosimilars Production Share by Manufacturers
Figure Global Biologics and Biosimilars Major Players Product Revenue (Million USD) (2013-2018)
Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table 2018 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics and Biosimilars Product Category
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics and Biosimilars Capacity (K Units) by Region (2013-2018)
Figure Global Biologics and Biosimilars Capacity Market Share by Region (2013-2018)
Figure Global Biologics and Biosimilars Capacity Market Share by Region (2013-2018)
Figure 2017 Global Biologics and Biosimilars Capacity Market Share by Region
Table Global Biologics and Biosimilars Production by Region (2013-2018)
Figure Global Biologics and Biosimilars Production (K Units) by Region (2013-2018)
Figure Global Biologics and Biosimilars Production Market Share by Region (2013-2018)
Figure 2017 Global Biologics and Biosimilars Production Market Share by Region
Table Global Biologics and Biosimilars Revenue (Million USD) by Region (2013-2018)
Table Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)
Figure Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)
Table 2017 Global Biologics and Biosimilars Revenue Market Share by Region
Figure Global Biologics and Biosimilars Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Southeast Asia Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table India Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Biologics and Biosimilars Consumption (K Units) Market by Region (2013-2018)
Table Global Biologics and Biosimilars Consumption Market Share by Region (2013-2018)
Figure Global Biologics and Biosimilars Consumption Market Share by Region (2013-2018)
Figure 2017 Global Biologics and Biosimilars Consumption (K Units) Market Share by Region
Table North America Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Biologics and Biosimilars Production (K Units) by Type (2013-2018)
Table Global Biologics and Biosimilars Production Share by Type (2013-2018)
Figure Production Market Share of Biologics and Biosimilars by Type (2013-2018)
Figure 2017 Production Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Revenue (Million USD) by Type (2013-2018)
Table Global Biologics and Biosimilars Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Biologics and Biosimilars by Type (2013-2018)
Figure 2017 Revenue Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Price (USD/Unit) by Type (2013-2018)
Figure Global Biologics and Biosimilars Production Growth by Type (2013-2018)
Table Global Biologics and Biosimilars Consumption (K Units) by Application (2013-2018)
Table Global Biologics and Biosimilars Consumption Market Share by Application (2013-2018)
Figure Global Biologics and Biosimilars Consumption Market Share by Applications (2013-2018)
Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2017
Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)
Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Pfizer Biologics and Biosimilars Production Market Share (2013-2018)
Figure Pfizer Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Roche Biologics and Biosimilars Production Market Share (2013-2018)
Figure Roche Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Amgen Biologics and Biosimilars Production Market Share (2013-2018)
Figure Amgen Biologics and Biosimilars Revenue Market Share (2013-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure AbbVie Biologics and Biosimilars Production Market Share (2013-2018)
Figure AbbVie Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Sanofi Biologics and Biosimilars Production Market Share (2013-2018)
Figure Sanofi Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Production Market Share (2013-2018)
Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Production Market Share (2013-2018)
Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Novartis Biologics and Biosimilars Production Market Share (2013-2018)
Figure Novartis Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Merck Biologics and Biosimilars Production Market Share (2013-2018)
Figure Merck Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lilly Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lilly Biologics and Biosimilars Production Growth Rate (2013-2018)
Figure Lilly Biologics and Biosimilars Production Market Share (2013-2018)
Figure Lilly Biologics and Biosimilars Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biologics and Biosimilars Price (Million USD) and Trend Forecast (2018-2025)
Table Global Biologics and Biosimilars Production (K Units) Forecast by Region (2018-2025)
Figure Global Biologics and Biosimilars Production Market Share Forecast by Region (2018-2025)
Table Global Biologics and Biosimilars Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Biologics and Biosimilars Consumption Market Share Forecast by Region (2018-2025)
Figure North America Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Biologics and Biosimilars Production (K Units) Forecast by Type (2018-2025)
Figure Global Biologics and Biosimilars Production (K Units) Forecast by Type (2018-2025)
Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2018-2025)
Table Global Biologics and Biosimilars Price Forecast by Type (2018-2025)
Table Global Biologics and Biosimilars Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Biologics and Biosimilars Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Online Payment

Research Assistance
We will be happy to help you find what you need. Please write to us:

E-Addresssales@qyresearchreports.us